STAY AHEAD WITH CLEARER
SKIN AND LESS ITCH

DUPIXENT in combination with a topical corticosteroid was studied in a 16-week
clinical trial in 367 patients ages 6-11 years with severe eczema not adequately
controlled with topical prescription treatments


Results from a clinical trial at 16 weeks (DUPIXENT* + topical corticosteroid [TCS] vs TCS only):

~2X
SAW CLEAR OR
ALMOST CLEAR SKIN

30% 300 mg DUPIXENT every 4 weeks
+ TCS vs 13% TCS only

39% 200 mg DUPIXENT every 2 weeks
+ TCS vs 10% TCS only

~4.5X
HAD noticeably
LESS ITCH

54% 300 mg DUPIXENT every 4 weeks
+ TCS vs 12% TCS only

61% 200 mg DUPIXENT every 2 weeks
+ TCS vs 13% TCS only

≥75%
Clearer skin
in more
than
half of
children

75% 300 mg DUPIXENT every 4 weeks + TCS vs 28% TCS only

75% 200 mg DUPIXENT every 2 weeks + TCS vs 26% TCS only

Your healthcare provider will tell you how much DUPIXENT to inject and how often.

*After an initial loading dose of 2 injections, children less than 66 lb received 300 mg every 4 weeks; children 66 lb or more received 200 mg every 2 weeks.

 

 

View BEFORE AND AFTER RESULTS
IN CHILDREN

Use the slider to view before and after results of an actual 10-year-old patient and 9-year-old patient after 16 weeks of treatment with DUPIXENT and a topical steroid in a phase 3 clinical trial. These patients met clinical trial criteria for clear or almost clear skin. Individual results may vary.

Click and drag
to see results
Click and drag
to see results

 

Most common side
effects include:

  • Injection site reactions
  • Eye and eyelid inflammation, including redness, swelling,
    and itching, sometimes with blurred vision
  • Dry eye
  • Cold sores in your mouth or on your lips
  • High count of a certain white blood cell (eosinophilia)

Long-term safety results for children continuing on DUPIXENT with or without TCS in the
pediatric extension study through 1 year were consistent with the adult clinical trials.

View the possible side effects of DUPIXENT in patients with moderate-to-severe eczema (atopic dermatitis).

What You Should Know About the Patients in This Study:

100%
Had severe
atopic dermatitis
~8.5 years
Average age
~58%
Average body surface
area involvement
DID YOU KNOW?

DUPIXENT is not a steroid
or immunosuppressant

I’m really proud of Catch taking
his DUPIXENT injection. At first,
he resisted, but now he sees the
benefits of taking DUPIXENT.

Amber,

DUPIXENT MyWay® Caregiver and Patient
Ambassador. Individual results may vary.

AMBER AND
CATCH'S STORY

ASK YOUR CHILD’S
DOCTOR ABOUT DUPIXENT

Use this personalized guide to have
a productive conversation
during your next visit.

Start the guide  

THE COST OF DUPIXENT

You could qualify for a copay as low as $0.
Use our cost and coverage tool to determine
your exact out-of-pocket cost.

CHECK ELIGIBILITY